Cite
HARVARD Citation
Yajima, Y. et al. (2022). A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. Cancer science. 113 (8), pp. 2526-2535. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yajima, Y. et al. (2022). A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. Cancer science. 113 (8), pp. 2526-2535. [Online].